Dental Implants in India and UAE | Complete Patient Guide

• IDEAL CANDIDATES:

• Adults (18+) with one or more missing teeth, congenitally absent teeth, or severely compromised teeth requiring extraction

• Patients with adequate residual alveolar bone height (≥ 10 mm) and width (≥ 6 mm) as confirmed on CBCT, OR patients willing to undergo concurrent or staged bone grafting / sinus lift procedures

• Patients with healthy or well-controlled systemic health: HbA1c < 8.0% for diabetics; stable cardiovascular status; no active chemotherapy or head-and-neck radiation within prior 12 months

• Non-smokers or former smokers (>1 year cessation strongly preferred; current smokers counselled on 2× higher failure risk)

• Patients dissatisfied with removable dentures seeking fixed, bone-anchored restorations

• Patients requiring full-arch rehabilitation (All-on-4 / All-on-6 protocol, zygomatic implants, or implant-supported overdentures)

• REQUIRED PRE-TREATMENT DIAGNOSTICS:

• Cone-Beam CT (CBCT) of the maxilla and/or mandible — mandatory for 3D bone mapping, proximity to inferior alveolar nerve (IAN) canal, and maxillary sinus floor assessment

• Full-mouth periapical and panoramic (OPG) radiographs

• Intraoral digital scans (iTero, 3Shape TRIOS) or polyvinyl siloxane (PVS) impressions for prosthetic planning

• Blood panel: CBC, fasting glucose, HbA1c, coagulation profile (INR/PT/aPTT), Vitamin D (25-OH), serum calcium

• Medical history screening: bisphosphonate / RANKL inhibitor use (risk of medication-related osteonecrosis of the jaw — MRONJ), immunosuppressant therapy, anticoagulant therapy (warfarin, DOACs — bridging protocol required)

• Periodontal assessment and bacterial biofilm scoring (BPE/CPITN) — active periodontal disease must be fully treated before implant placement

• HIV/HBsAg/HCV serology (standard pre-surgical screening at most accredited centres)

• RELATIVE AND ABSOLUTE CONTRAINDICATIONS:

• Active head-and-neck radiation therapy or history of high-dose radiotherapy (>50 Gy) to the jaws without HBO clearance

• Uncontrolled diabetes (HbA1c > 9%)

• Active bisphosphonate or denosumab therapy for oncological indications (IV formulations — high MRONJ risk)

• Active oral bisphosphonate therapy > 4 years without drug holiday and CTX < 150 pg/mL

• Severe thrombocytopenia, bleeding diatheses, or inability to discontinue anticoagulants peri-operatively

• Active smoking combined with severe bone deficiency (relative; risk-benefit discussion required)

• Uncontrolled psychiatric conditions or bruxism without occlusal splint management

• Insufficient residual bone WITHOUT willingness to undergo staged augmentation (sinus lift, GBR, block grafting)

STANDARD SINGLE-STAGE AND TWO-STAGE IMPLANT PLACEMENT:

The conventional two-stage protocol involves surgical placement of a submerged implant fixture with a healing cap at Stage 1, a healing period of 8–16 weeks for osseointegration, and Stage 2 abutment connection and prosthetic loading. This approach is preferred in low-density (Type III–IV) bone, post-extraction sockets requiring GBR, or patients with systemic risk factors. Single-stage (non-submerged) placement uses a transmucosal healing abutment from day one and reduces total treatment time by eliminating a second surgical appointment.

IMMEDIATE IMPLANT PLACEMENT AND IMMEDIATE LOADING (SAME-DAY TEETH):

For patients with a tooth requiring extraction and adequate buccal bone plate integrity, immediate implant placement into the fresh socket (Type 1 placement) combined with a provisional crown delivery within 24–48 hours (immediate temporisation) is an evidence-supported protocol. ISQ measurement via Osstell™ resonance frequency analysis must confirm primary stability ≥ 70 ISQ before immediate loading is attempted. This protocol is particularly well-suited to the anterior maxilla for aesthetic outcomes.

ALL-ON-4 AND ALL-ON-6 FULL-ARCH REHABILITATION:

The All-on-4® concept (Nobel Biocare) uses four implants — two axial anterior fixtures and two posterior fixtures tilted 30–45° to maximise engagement of available bone and avoid the maxillary sinus or IAN canal — to support a fixed full-arch prosthesis on the day of surgery. All-on-6 uses six implants for additional posterior support and load distribution. These protocols are indicated for fully or extensively edentulous patients and can often eliminate the need for bone grafting. The definitive zirconia or acrylic-on-titanium bar prosthesis is fitted 3–6 months after initial placement following final osseointegration.

ZYGOMATIC IMPLANTS (for severe maxillary atrophy):

In patients with severely resorbed maxillae where conventional implants and sinus augmentation are not viable, zygomatic implants (45–52.5 mm length, angled through the zygomatic arch) provide bicortical anchorage in dense zygomatic bone. The ZAGA (Zygomatic Anatomy-Guided Approach) protocol customises the implant trajectory based on CBCT anatomy, reducing sinus perforation rates. Typically 2–4 zygomatic implants support a full maxillary arch.

COMPUTER-GUIDED AND ROBOTIC-ASSISTED IMPLANT SURGERY:

Using pre-surgical CBCT data merged with digital prosthetic planning, a surgical guide stent (static computer-aided implant surgery — sCAIS) or dynamic navigation system (Navident®, X-Guide®) directs the drill osteotomy to within ±0.1–0.3 mm of the planned trajectory. This approach is particularly critical near the IAN canal, in the posterior maxilla adjacent to the sinus floor, and in All-on-4 cases. Select GAF Healthcare partner centres in India and the UAE deploy the Yomi® robotic guidance system — the world's first FDA-cleared robotics platform for dental implant surgery — offering real-time haptic feedback and deviation alerts during osteotomy preparation.

BONE AUGMENTATION PROCEDURES (enabling implants in deficient ridges):

• Lateral window sinus lift (Tatum technique): adds bone graft to the maxillary sinus floor for posterior maxillary implants requiring ≥ 4 mm sub-sinus bone

• Transcrestal (osteotome) sinus lift: minimally invasive, limited to ≤ 4 mm vertical gain

• Guided Bone Regeneration (GBR): collagen membrane (Bio-Gide®) over particulate graft (autograft, xenograft, or alloplast) for horizontal ridge defects

• Autogenous block grafting (chin, ramus, iliac crest): reserved for large-volume deficiencies

• PRF (Platelet-Rich Fibrin, Choukroun protocol): autologous growth factor concentrate derived from centrifuged patient blood, used to accelerate healing and reduce post-operative complications — widely adopted at partner centres

PROSTHETIC OPTIONS:

• Single implant crown: monolithic zirconia (strongest), lithium disilicate (aesthetic), PFM

• Implant-supported bridge (3–6 units)

• Implant-retained overdenture: ball attachment, locator abutment, or bar-retained

• Fixed full-arch: zirconia monolithic bridge, hybrid (acrylic teeth on titanium milled bar)

PHASE 1 — REMOTE PRE-CONSULTATION (2–4 weeks before travel):

• Upload existing OPG/CBCT scans, medical records, blood reports, and medication list to GAF Healthcare's secure patient portal

• Video consultation with implantologist: treatment plan confirmed, staging discussed (single visit vs. two-phase for implant placement + loading)

• GAF Healthcare coordinates e-Medical Visa application for India or UAE entry visa assistance

• Quotation and cost lock-in provided in writing; implant brand confirmed (Nobel Biocare, Straumann, or equivalent)

PHASE 2 — ARRIVAL AND CLINICAL ASSESSMENT (Day 1–2):

• Airport transfer arranged by GAF Healthcare

• Clinical examination, intraoral digital scanning, and fresh CBCT if local scans are unavailable or outdated

• Blood tests completed at partner diagnostic lab; results typically in 4–8 hours

• Anaesthesiologist consultation if IV sedation or general anaesthesia is requested

• Final treatment plan and consent documentation completed

• PRF blood draw and centrifugation scheduled for day of surgery

PHASE 3 — SURGICAL PROCEDURE (Day 2–4 depending on complexity):

• Single implant (local anaesthesia): 45–90 minutes. Crestal incision, osteotomy with stepped drills under copious saline irrigation, implant insertion with 35–45 Ncm torque, ISQ measurement, healing cap or immediate provisional placement

• Multiple implants / All-on-4: 3–5 hours under IV sedation or general anaesthesia. Extractions if required, guided bone reduction, four-six implant placements with ISQ verification, provisional full-arch prosthesis fitted same day

• Bone grafting / sinus lift if concurrent: adds 30–90 minutes per site

• Post-surgical CBCT or periapical X-ray confirms implant angulation and depth

PHASE 4 — IMMEDIATE POST-OPERATIVE RECOVERY (Day 0–7):

• Discharge same day with prescribed analgesics (NSAIDs ± paracetamol; opioids rarely required), antibiotics (amoxicillin/clavulanate or clindamycin for penicillin-allergy), chlorhexidine 0.12% mouthwash, and dietary instructions (soft/liquid diet)

• Swelling peaks at 48–72 hours; cold compress protocol and head elevation advised

• Sutures (resorbable or non-resorbable): reviewed at Day 7–10

• GAF Healthcare accommodation includes recovery-friendly meals; attendant accommodation organised

• FIT-TO-FLY: Single implants — 3–5 days post-surgery; All-on-4/sinus lift — 7–14 days minimum (cabin pressure changes and nasal congestion create risk of sinus graft displacement in early post-operative period)

PHASE 5 — OSSEOINTEGRATION PERIOD (Weeks 2–16, managed remotely):

• Patient returns home; monthly teleconsultation with implantologist via GAF Healthcare platform

• X-rays taken at local dentist at 6–8 week mark and shared with treating team for remote assessment

• Mandibular implants typically integrate in 8–12 weeks; maxillary and grafted sites in 12–16 weeks

• Patients avoid hard foods, maintain scrupulous oral hygiene (soft electric toothbrush, interdental brushes, water flosser)

PHASE 6 — SECOND VISIT: ABUTMENT AND CROWN PLACEMENT (Week 12–20):

• Return trip to India or UAE (typically 5–7 days)

• Abutment connection, final digital impression, shade matching

• CAD/CAM crown or full-arch prosthesis fabricated (1–3 days in laboratory)

• Crown delivery, occlusal adjustment, bite registration

• Final OPG confirms marginal bone levels

PHASE 7 — LONG-TERM MAINTENANCE:

• Annual professional implant maintenance at local dentist

• Annual OPG for crestal bone level monitoring (acceptable crestal bone loss: < 0.2 mm/year after the first year)

• Occlusal splint prescribed for bruxers to protect implant prosthetics